<-- home page
join the network (professional only)
 
   
working group
background
project
contact
credits
new
link
 
Aim
 
To establish an International network of treatment centres in order to perform a prospective follow-up study on women affected by severe haemostatic disorders including von Willebrand disease, rare bleeding disorders, platelet disorders
 
Primary goals
 
First study
the goal of the first study (3 years) will be to address the first described goal

 

To evaluate the prevalence of gynaecological problems:
   
  ico menarche
  ico ovulation bleeding
  ico menorrhagia
  ico bleeding during pregnancy
  ico postpartum bleeding
   
ico To evaluate the association between menstrual loss and clinical severity (other bleeding symptoms)
ico To evaluate the association between laboratory phenotype and clinical severity
ico To determine the best treatment options to reduce the complications of menorrhagia and others gynaecological problems and eventually to understand which proportion of affected women requires regular prophylactic treatment
ico To collect and analyse data on concomitant gynaecological abnormalities, complications of menorrhagia (anaemia), requirement of gynaecological intervention
ico To evaluate the occurrence of abortion, miscarriage and other pregnancy complications in each disorder
 
 
Duration of the project
 
3 years (2008-2011)
 
 
Partners
   
Principal investigator: Flora Peyvandi, University of Milan

Data analysis: Marta Spreafico, Simona Maria Siboni, University of Milan

Supervision: F.R. Rosendaal, Leiden University of Medicine

Collaborating partners: Andra H. James, Duke University Medical Center, Durham, NC, USA
  Rezan Kadir, Royal Free Hospital Hampstead, London UK
  Christine Lee, Oxford University, UK
  Magdy El-Ekiaby, Shabrawishi Hospital, Cairo Egypt
  Peter Kouides, Duke University of Medicine, Durham USA
  Augusto B. Federici, University of Milan
  Jenny Goudemand, Hopital cardiologique, Lille France
  Annie Borel-Derlon, Hopital Cote de Nacre, Caen, France
  Giancarlo Castaman, S.Bortolo Hospital, Vicenza Italy
  Mans Edlund, Gyn Karolinska Hospital, Stockholm Sweden
  Manijeh Lak, Imam Khomeini Hospital, Tehran Iran
  Mehran Karimi, University of Medical Sciences, Shiraz Iran
  Danijela Mikovic, Blood Transfusion Institute, Belgrade, Serbia
 
last update 21 october 2009
© 2010 Fondazione Luigi Villa